SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound. 

This recall is due to reports of “increased resistance” when using the devices. There have been 194 customer complaints about the issue so far. 

Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.

Patients who need renal replacement therapy after TAVR are much less likely to survive. Researchers hope their new risk score can help care teams prepare ahead of time for this rare, but potentially fatal complication. 

Research published in 2018 caused many in the cardiology community to shy away from using these devices, and the FDA even issued warnings about their safety. However, new data suggest paclitaxel-coated balloons and stents are safe. 

Hoping to gain a better understanding of how TAVR may impact a patient’s long-term cardiovascular health, researchers explored data from more than 200,000 patients and shared their findings in JACC: Cardiovascular Interventions.

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

Healthcare giants Boston Scientific, Johnson & Johnson and Medtronic were all reportedly interested in acquiring Shockwave Medical in 2023. Now, new rumors suggest a deal could be finalized within weeks.